Effects of a New Hormone Therapy, Drospirenone and 17-β-Estradiol, in Postmenopausal Women With Hypertension
نویسندگان
چکیده
منابع مشابه
Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.
Drospirenone (DRSP), a progestin with antialdosterone activity, has been developed for hormone therapy in combination with 17-beta-estradiol (E2) in postmenopausal women. We evaluated the antihypertensive efficacy and safety of various doses of DRSP and E2 and estradiol alone in postmenopausal women with hypertension using ambulatory and clinic blood pressure (BP) monitoring. This was a randomi...
متن کاملEffects of a New Hormone Therapy, Drospirenone and 17- -Estradiol, in Postmenopausal Women With Hypertension
Drospirenone (DRSP), a progestin with antialdosterone activity, has been developed for hormone therapy in combination with 17-estradiol (E2) in postmenopausal women. We evaluated the antihypertensive efficacy and safety of various doses of DRSP and E2 and estradiol alone in postmenopausal women with hypertension using ambulatory and clinic blood pressure (BP) monitoring. This was a randomized, ...
متن کاملA new hormone therapy with drospirenone and NO production in postmenopausal women.
A New Hormone Therapy With Drospirenone and NO Production in Postmenopausal Women To the Editor: We read with great interest the article by White et al1 dealing with the combination therapy of drospirenone (DRSP), a novel progestin with antialdosterone activity, and 17-estradiol (E2) in postmenopausal women. The results of their study demonstrated that DRSP and E2 might have a significant antih...
متن کاملPercutaneous 17 beta-estradiol replacement therapy in hypertensive postmenopausal women.
The present study evaluated the short-term effects of percutaneous 17 beta-estradiol on blood pressure, metabolic profile and hormonal levels in postmenopausal women with systemic arterial hypertension. After a wash-out period of 15 days, 10 hypertensive patients were treated with guanabenz acetate to control blood pressure, followed by 17 beta-estradiol in the form of hydroalcoholic gel admini...
متن کاملEfficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women
This regulatory post-marketing surveillance study aimed to evaluate the therapeutic efficacy and safety of drospirenone (DRSP) 2 mg/estradiol (E2) 1 mg tablet in Korean postmenopausal women. A total of 4,149 patients were enrolled and the study was conducted at 207 clinical research centers. The patients' source data was collected between November 2006 and November 2012. More than 85% of patien...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Hypertension
سال: 2006
ISSN: 0194-911X,1524-4563
DOI: 10.1161/01.hyp.0000232179.60442.84